In our quest to provide holistic pet products, Vitality Science has stumbled upon an interesting discovery. An anecdotal story about dog dewormer for cancer has gone viral online and is being talked about in some of the most rigorous peer-reviewed scientific journals in the world.
The story begins with a man named Joe Tippens, who was diagnosed with a type of lung cancer and told that he had only a short time to live. He pursued a treatment regimen that included fenbendazole, sold under the commercial name Panacur, which is commonly used to treat parasites in dogs and cats. He claims that after three months on his regimen, a PET scan showed that he is cancer free.
Although some peer-reviewed studies have found potential for fenbendazole as an anticancer drug, there is no proof that it cures cancer in humans. It does appear to suppress the growth of microtubules, which give structure to cells, and targets certain cancer cell mutations.
However, it’s important to remember that even the most promising medical breakthroughs often take a long time to come to market, and there are many different types of cancer. It’s also important to note that this research isn’t intended as a replacement for existing treatments such as chemotherapy and radiation, which have helped many people survive cancer.
More recently, the big buzz in cancer immunotherapy has been around checkpoint inhibitors like PD-1 and CAR T cells, which have shown great promise against melanoma and leukemia. But one of the earliest milestones in immunotherapy happened in dogs, and it involved something called “dendritic cell vaccination,” an approach pioneered by Penn Vet researchers and the Donaldson-Atwood Cancer Clinic. dog dewormer for cancer